Morgan Stanley’s CAS Medical Systems, Inc. CASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-345
| Closed | -$1K | – | 6913 |
|
|
2019
Q1 | $1K | Sell |
345
-5
| -1% | -$11 | ﹤0.01% | 6567 |
|
|
2018
Q4 | $0 | Sell |
350
-150
| -30% | -$279 | ﹤0.01% | 6860 |
|
|
2018
Q3 | $1K | Buy |
500
+85
| +20% | +$181 | ﹤0.01% | 6690 |
|
|
2018
Q2 | $1K | Sell |
415
-1,963
| -83% | -$2.93K | ﹤0.01% | 6636 |
|
|
2018
Q1 | $3K | Buy |
2,378
+1,657
| +230% | +$1.87K | ﹤0.01% | 6477 |
|
|
2017
Q4 | $0 | Sell |
721
-2,556
| -78% | -$1.87K | ﹤0.01% | 6758 |
|
|
2017
Q3 | $3K | Sell |
3,277
-352
| -10% | -$361 | ﹤0.01% | 6383 |
|
|
2017
Q2 | $4K | Buy |
3,629
+1,579
| +77% | +$1.8K | ﹤0.01% | 6394 |
|
|
2017
Q1 | $3K | Buy |
2,050
+1,850
| +925% | +$2.81K | ﹤0.01% | 6437 |
|
|
2016
Q4 | $0 | Buy |
+200
| New | +$336 | ﹤0.01% | 6613 |
|
|
2016
Q2 | – | Sell |
-40
| Closed | – | – | 6774 |
|
|
2016
Q1 | $0 | Sell |
40
-7
| -15% | -$11 | ﹤0.01% | 6829 |
|
|
2015
Q4 | $0 | Buy |
+47
| New | +$66 | ﹤0.01% | 6903 |
|
|
2015
Q3 | – | Sell |
-46
| Closed | – | – | 6819 |
|
|
2015
Q2 | $0 | Buy |
46
+1
| +2% | +$1 | ﹤0.01% | 6834 |
|
|
2015
Q1 | $0 | Buy |
45
+12
| +36% | +$17 | ﹤0.01% | 6737 |
|
|
2014
Q4 | $0 | Sell |
33
-123
| -79% | -$217 | ﹤0.01% | 6748 |
|
|
2014
Q3 | $0 | Sell |
156
-432
| -73% | -$745 | ﹤0.01% | 6732 |
|
|
2014
Q2 | $1K | Buy |
588
+433
| +279% | +$917 | ﹤0.01% | 6460 |
|
|
2014
Q1 | $0 | Buy |
155
+32
| +26% | +$68 | ﹤0.01% | 6603 |
|
|
2013
Q4 | $0 | Buy |
+123
| New | +$192 | ﹤0.01% | 6379 |
|
Morgan Stanley's CASM Position: Q2 2019 in Review
Morgan Stanley sold out of CAS Medical Systems, Inc. (CASM) in Q2 2019, closing a stake of 345 shares — an estimated $1K sold.
Morgan Stanley first reported a position in CASM in Q4 2013 and held it in 19 quarters. The position peaked at $4K in Q2 2017. 0 funds tracked by Wall St. Rank hold CASM as of Q2 2019.
- Morgan Stanley reported no remaining CAS Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
- Morgan Stanley sold 345 CAS Medical Systems, Inc. shares in Q2 2019, an estimated $1K.
- Morgan Stanley first reported a position in CAS Medical Systems, Inc. in Q4 2013 and held it in 19 quarters.
- Morgan Stanley's CAS Medical Systems, Inc. position peaked at $4K in Q2 2017.
- 0 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q2 2019.
Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.